Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-24

Clinical Trial Update: A Randomized Controlled Trial With Rituximab for Psychotic Disorder in Adults [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial is evaluating Rituximab for adults with schizophrenia spectrum and other psychotic disorders; the study is currently active but not r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rituximab (rituximab)

Snippet

Sponsor: Region Örebro County | Conditions: Schizophrenia Spectrum and Other Psychotic Disorders | Phase 2 | Status: ACTIVE_NOT_RECRUITING